Molecular Subtypes of High-Grade Serous Ovarian Cancer across Racial Groups and Gene Expression Platforms

Abstract

Background:

High-grade serous carcinoma (HGSC) gene expression subtypes are associated with differential survival. We characterized HGSC gene expression in Black individuals and considered whether gene expression differences by self-identified race may contribute to poorer HGSC survival among Black versus White individuals.

Methods:

We included newly generated RNA sequencing data from Black and White individuals and array-based genotyping data from four existing studies of White and Japanese individuals. We used K-means clustering, a method with no predefined number of clusters or dataset-specific features, to assign subtypes. Cluster- and dataset-specific gene expression patterns were summarized by moderated t-scores. We compared cluster-specific gene expression patterns across datasets by calculating the correlation between the summarized vectors of moderated t-scores. After mapping to The Cancer Genome Atlas–derived HGSC subtypes, we used Cox proportional hazards models to estimate subtype-specific survival by dataset.

Results:

Cluster-specific gene expression was similar across gene expression platforms and racial groups. Comparing the Black population with the White and Japanese populations, the immunoreactive subtype was more common (39% vs. 23%–28%) and the differentiated subtype was less common (7% vs. 22%–31%). Patterns of subtype-specific survival were similar between the Black and White populations with RNA sequencing data; compared with mesenchymal cases, the risk of death was similar for proliferative and differentiated cases and suggestively lower for immunoreactive cases [Black population HR = 0.79 (0.55, 1.13); White population HR = 0.86 (0.62, 1.19)].

Conclusions:

Although the prevalence of HGSC subtypes varied by race, subtype-specific survival was similar.

Impact:

HGSC subtypes can be consistently assigned across platforms and self-identified racial groups.

Funding
Discovery of Novel Rare Variants as Ovarian Cancer Susceptibility FactorsCharacterization of high-grade serous ovarian cancer subtypes via single-cell profilingEpidemiology of Ovarian Cancer in African-American WomenThe Role of Inflammation in the Racial Disparities in Ovarian Cancer SurvivalInflammation and gynecologic cancer: the role of prostaglandins in ovarian cancerThe Role of Inflammation in the Racial Disparities in Ovarian Cancer SurvivalCancer Research Career Enhancement and Related ActivitiesCancer Research Career Enhancement and Related ActivitiesCharacterizing Molecular Subtypes of Ovarian Cancer in African-American WomenThe Molecular Epidemiology Of Ovarian CancerCharacterizing Molecular Subtypes of Ovarian Cancer in African-American WomenEpidemiology of Ovarian Cancer in African-American WomenThe Molecular Epidemiology Of Ovarian CancerDiscovery of Novel Rare Variants as Ovarian Cancer Susceptibility FactorsCharacterization of high-grade serous ovarian cancer subtypes via single-cell profilingInflammation and gynecologic cancer: the role of prostaglandins in ovarian cancer

NCI NIH HHS

R01 CA188943

NCI NIH HHS

R01 CA237170

NCI NIH HHS

R01 CA142081

NCI NIH HHS

R00 CA218681

NCI NIH HHS

K00 CA212222

National Cancer Institute (NCI)

R00CA218681

NCI NIH HHS

P30 CA042014

National Cancer Institute (NCI)

P30CA042014

NCI NIH HHS

R01 CA200854

NCI NIH HHS

R01 CA076016

National Cancer Institute

R01 CA200854

National Cancer Institute

R01 CA142081

National Cancer Institute

R01 CA076016

National Cancer Institute

R01 CA188943

National Cancer Institute

R01 CA237170

National Cancer Institute

R00CA218681

National Cancer Institute

P30CA042014

National Cancer Institute

K00 CA212222